{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-023183","form_type":"8-K","ticker":"VICP","cik":"0001468639","company_name":"Vicapsys Life Sciences, Inc.","filed_at":"2023-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.957182+00:00","generated_at":"2026-06-13T13:52:53.090610+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vicapsys Life Sciences issues $330K note to AJB Capital, 10% interest, 8% OID, due Dec 2023","bullets":["Principal $330,000, purchase price $303,600 (8% OID), 10% annual interest, maturity December 27, 2023.","Issued 328,571 unregistered commitment fee shares to AJB Capital as part of the agreement.","Default triggers 150% acceleration, 18% interest, and conversion at average of 3 lowest VWAP prices.","Proceeds from the note will be used for general working capital purposes.","Note is convertible into common stock upon an event of default at a formula-based conversion price."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-023183","json":"https://secwatch.observer/filing/0001493152-23-023183.json","markdown":"https://secwatch.observer/filing/0001493152-23-023183.md","text":"https://secwatch.observer/filing/0001493152-23-023183.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/0001493152-23-023183-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:52:53.090610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d3437855dd388701b3d29af9b0fb65b6f288ddf3","claim":"Vicapsys Life Sciences, Inc. incurred loan of $330,000 with AJB Capital Investments, LLC at 10% a year maturing December 27, 2023.","evidence_excerpt":"On June 27, 2023, we entered into a securities purchase agreement (the “SPA”) with AJB Capital Investments, LLC (“AJB”) and issued a promissory note in the principal amount of $330,000 (the “note”) to AJB pursuant to the SPA for an purchase price of $303,600.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/0001493152-23-023183-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$330,000"},{"label":"Counterparty","value":"AJB Capital Investments, LLC"},{"label":"Rate","value":"10% a year"},{"label":"Maturity","value":"December 27, 2023"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"902a1051a33e9f17198968efe7d23a4b1a98c4f3","claim":"Vicapsys Life Sciences, Inc. entered into SPA with AJB Capital Investments, LLC valued at principal amount of $330,000 (effective 2023-06-27).","evidence_excerpt":"On June 27, 2023, we entered into a securities purchase agreement (the \"SPA\") with AJB Capital Investments, LLC (\"AJB\") and issued a promissory note in the principal amount of $330,000 (the \"note\") to AJB pursuant to the SPA for an purchase price of $303,600.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468639/000149315223023183/0001493152-23-023183-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"AJB Capital Investments, LLC"},{"label":"Value","value":"principal amount of $330,000"},{"label":"Effective","value":"2023-06-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}